Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 74 (1-3) , 225-232
- https://doi.org/10.1016/s0168-3659(01)00320-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antiproliferative Effect of a Lectin- and Anti-Thy-1.2 Antibody-Targeted HPMA Copolymer-Bound Doxorubicin on Primary and Metastatic Human Colorectal Carcinoma and on Human Colorectal Carcinoma Transfected with the Mouse Thy-1.2 GeneBioconjugate Chemistry, 2000
- Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fateJournal of Controlled Release, 1998
- Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigensJournal of Controlled Release, 1998
- Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin AJournal of Controlled Release, 1996
- Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanomaBritish Journal of Cancer, 1994
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Antibody-targeted cyclosporin AJournal of Controlled Release, 1992
- Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemiaBritish Journal of Cancer, 1988
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitroBritish Journal of Cancer, 1987